CCND1 and breast carcinoma: The lignan was also used to assess the effect of down-regulation of cyclin D1 protein expression in different types of human tumor cells including the breast cancer cell line T-47D, the lung cancer cell line A549, the transformed renal cell line 293T, the immortalized keratinocyte cell line HaCaT, the melanoma cell line UACC-62 and the osteosarcoma cell line MG63, which proved that suppression of sesamin generally occurs in the tumor cells.